Clinical factors related to long-term administration of sorafenib in patients with hepatocellular carcinoma

BACKGROUND: Sorafenib has been approved in the indication of unresectable hepatocellular carcinoma, but there are many cases in which administration of the drug is discontinued due to severe side effects. In this study, we compared the characteristics of patients who continued and discontinued soraf...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Nojiri, Shunsuke, Kusakabe, Atsunori, Fujiwara, Kei, Shinkai, Noboru, Matsuura, Kentaro, Iio, Etsuko, Miyaki, Tomokatsu, Nomura, Tomoyuki, Sobue, Satoshi, Sano, Hitoshi, Hasegawa, Izumi, Ohno, Tomoyoshi, Takahashi, Yoshitsugu, Orito, Etsuro, Joh, Takashi
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove Medical Press 2012
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3534393/
https://ncbi.nlm.nih.gov/pubmed/23293537
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S38684
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi